Literature DB >> 15114626

Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.

Michael W Jakowec1, Kerry Nixon, Elizabeth Hogg, Tom McNeill, Giselle M Petzinger.   

Abstract

Administration of the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to C57BL/6 mice targets nigrostriatal dopaminergic neurons, leading to cell death and the depletion of striatal dopamine. After MPTP lesioning in young adult mice, surviving nigrostriatal dopaminergic neurons display robust and reproducible return of striatal dopamine weeks to months after injury. Thus, the mouse provides an excellent model with which to investigate the mechanisms underlying neuroplasticity of the nigrostriatal system following neurotoxic injury. The purpose of this study was to analyze proteins and mRNA transcripts of genes involved in dopamine biosynthesis (tyrosine hydroxylase; TH) and uptake (dopamine transporter; DAT) with regard to time course (7-90 days) after MPTP lesioning. Molecular analysis using immunohistochemistry and Western immunoblotting techniques demonstrated an increase in striatal TH by 30-60 days postlesioning that returned to near-control (prelesioned) levels by 60-90 days. In situ hybridization histochemistry indicated that this increase in TH protein might be due in part to increased TH mRNA expression in surviving nigrostriatal dopaminergic neurons. Analysis of TH protein at 7, 30, 60, and 90 days postlesioning with two-dimensional polyacrylamide gel electrophoresis in conjunction with Western immunoblotting revealed altered TH protein isoforms migrating at isoelectric points different from those of the native isoform. In contrast to TH protein, which returned to prelesioned levels by 60 days, DAT protein analysis showed that increased expression of striatal DAT protein did not return to near-prelesion levels until 90 days postlesioning. These results suggest that TH and DAT may differ in their time course of expression in surviving dopaminergic neurons and may play a role in mediating the return of striatal dopamine. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114626     DOI: 10.1002/jnr.20114

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  39 in total

1.  Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.

Authors:  Hironori Yokoyama; Ryohei Yano; Hayato Kuroiwa; Tatsuya Tsukada; Hiroto Uchida; Hiroyuki Kato; Jiro Kasahara; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2010-04-28       Impact factor: 3.584

2.  Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.

Authors:  Eleni Antzoulatos; Michael W Jakowec; Giselle M Petzinger; Ruth I Wood
Journal:  Pharmacol Biochem Behav       Date:  2010-03-27       Impact factor: 3.533

3.  A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse.

Authors:  Z C Baquet; D Williams; J Brody; R J Smeyne
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

4.  Regulation of bat echolocation pulse acoustics by striatal dopamine.

Authors:  Jedediah Tressler; Christine Schwartz; Paul Wellman; Samuel Hughes; Michael Smotherman
Journal:  J Exp Biol       Date:  2011-10-01       Impact factor: 3.312

5.  Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  F L'Episcopo; C Tirolo; N Testa; S Caniglia; M C Morale; C Cossetti; P D'Adamo; E Zardini; L Andreoni; A E C Ihekwaba; P A Serra; D Franciotta; G Martino; S Pluchino; B Marchetti
Journal:  Neurobiol Dis       Date:  2010-11-05       Impact factor: 5.996

6.  Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.

Authors:  Joshua D Gross; Shane W Kaski; Adam B Schroer; Kimberley A Wix; David P Siderovski; Vincent Setola
Journal:  J Psychopharmacol       Date:  2018-01-24       Impact factor: 4.153

7.  ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.

Authors:  Michael F Salvatore
Journal:  J Neurochem       Date:  2014-01-27       Impact factor: 5.372

8.  Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra.

Authors:  A Ostergren; A Fredriksson; E B Brittebo
Journal:  J Neural Transm (Vienna)       Date:  2005-08-03       Impact factor: 3.575

9.  Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice.

Authors:  Chie Oki; Yu Watanabe; Hironori Yokoyama; Taiji Shimoda; Hiroyuki Kato; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2008-01-17       Impact factor: 5.046

10.  Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons.

Authors:  Xiqun Chen; Lu Xu; Pheona Radcliffe; Baoyong Sun; A William Tank
Journal:  Mol Pharmacol       Date:  2008-03-18       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.